Geode Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-205,402
| Closed | -$2.35M | – | 4527 |
|
|
2020
Q4 | $2.35M | Sell |
205,402
-2,441
| -1% | -$27.8K | ﹤0.01% | 2995 |
|
|
2020
Q3 | $1.43M | Buy |
207,843
+249
| +0.1% | +$1.64K | ﹤0.01% | 3059 |
|
|
2020
Q2 | $1.35M | Sell |
207,594
-22,668
| -10% | -$146K | ﹤0.01% | 3037 |
|
|
2020
Q1 | $1.52M | Buy |
230,262
+3,075
| +1% | +$26.8K | ﹤0.01% | 2819 |
|
|
2019
Q4 | $2.35M | Sell |
227,187
-4,782
| -2% | -$40.9K | ﹤0.01% | 2917 |
|
|
2019
Q3 | $1.47M | Sell |
231,969
-5,188
| -2% | -$38.7K | ﹤0.01% | 3085 |
|
|
2019
Q2 | $1.76M | Buy |
237,157
+36,495
| +18% | +$241K | ﹤0.01% | 3030 |
|
|
2019
Q1 | $1.23M | Sell |
200,662
-4,847
| -2% | -$56.2K | ﹤0.01% | 3076 |
|
|
2018
Q4 | $2.37M | Buy |
205,509
+45,142
| +28% | +$770K | ﹤0.01% | 2680 |
|
|
2018
Q3 | $3.47M | Buy |
160,367
+36,043
| +29% | +$682K | ﹤0.01% | 2591 |
|
|
2018
Q2 | $1.96M | Buy |
124,324
+32,642
| +36% | +$513K | ﹤0.01% | 2870 |
|
|
2018
Q1 | $1.73M | Buy |
91,682
+3,867
| +4% | +$76.3K | ﹤0.01% | 2844 |
|
|
2017
Q4 | $1.53M | Buy |
87,815
+996
| +1% | +$13.7K | ﹤0.01% | 2905 |
|
|
2017
Q3 | $1.3M | Buy |
86,819
+2,358
| +3% | +$37K | ﹤0.01% | 2999 |
|
|
2017
Q2 | $1.57M | Buy |
84,461
+6,735
| +9% | +$117K | ﹤0.01% | 2876 |
|
|
2017
Q1 | $1.31M | Buy |
77,726
+2,180
| +3% | +$43.5K | ﹤0.01% | 2886 |
|
|
2016
Q4 | $1.61M | Buy |
75,546
+8,443
| +13% | +$173K | ﹤0.01% | 2754 |
|
|
2016
Q3 | $1.23M | Buy |
67,103
+17,993
| +37% | +$406K | ﹤0.01% | 2837 |
|
|
2016
Q2 | $1.42M | Buy |
+49,110
| New | +$1.37M | ﹤0.01% | 2708 |
|
Geode Capital Management's ARA Position: Q1 2021 in Review
Geode Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 205,402 shares — an estimated $2.35M sold.
Geode Capital Management first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $3.47M in Q3 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Geode Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Geode Capital Management sold 205,402 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $2.35M.
- Geode Capital Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Geode Capital Management's American Renal Associates Holdings, Inc position peaked at $3.47M in Q3 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Geode Capital Management's 13F filing for Q1 2021, filed 12 May 2021.